Skin regeneration cosmetic compositions containing sucralfate
A cosmetic composition containing sucralfate, fructan, and hyaluronic acid addresses skin aging issues such as wrinkles, loss of elasticity, and skin damage, achieving skin regeneration and moisturizing effects.
Patent Information
- Application Number
- CN202310936329.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2022-07-27
- Filing Date
- 2023-07-27
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2043-07-27
AI Technical Summary
Current technologies struggle to effectively address the problems of wrinkles, reduced elasticity, atrophy, and skin damage caused by skin aging.
Cosmetic compositions containing sucralfate, fructan, and hyaluronic acid or their salts or derivatives enhance the structure of the skin's basement membrane, promote the expression of laminin 332, type XVII collagen, and filaggrin, reduce the expression of interleukin-6, and promote skin regeneration and hydration.
It significantly improves skin regeneration, enhances skin elasticity, reduces wrinkles, improves skin damage, and restores gene expression and the function of the dermal-epidermal junction.
Smart Images

Figure BDA0004363578130000051 
Figure BDA0004363578130000181 
Figure BDA0004363578130000191
Abstract
Description
Technical Field
[0001] This invention relates to cosmetic compositions for skin regeneration containing sucralfate. Background Technology
[0002] As the body organ that directly contacts the external environment, the skin has the function of protecting the body's internal structure. It is a complex organ composed of cells with various functions and substances with corresponding physical properties. The skin can be broadly divided into three layers: the epidermis, dermis, and hypodermis. The dermis contains elastic solid substances (fibers) and viscous liquid substances, allowing the skin to maintain its inherent elasticity. Typically, with age, the skin is exposed to environmental factors such as ultraviolet radiation, pollution, and stress, leading to decreased skin function and atrophic changes, including a reduction in the number of skin cells and a decrease in skin thickness.
[0003] It is known that the increase in skin wrinkles and the decrease in skin elasticity are due to the deformation and reduction of the extracellular matrix (ECM) in the dermis, which affects the structural and functional changes of the basement membrane between the epidermis and dermis, or skin aging. It has been reported that the basement membrane in the skin of the elderly is damaged and destroyed, and that the basement membrane is also damaged in the skin of young people in their 20s, such as the face, which is exposed to ultraviolet rays. The structural and functional changes of the skin basement membrane are due to the following reasons: the activity of protein-degrading enzymes such as plasmin and matrix metalloproteinase (MMP) that decompose the structural components of the skin basement membrane increases due to ultraviolet rays and destroys the structural components of the basement membrane. With age, the expression of laminin 332(5), collagen IV, collagen XVII, collagen VII, etc., which are structural components of the basement membrane, also decreases (Mechanisms of Ageing and Development. 156, 14-16, 2016).
[0004] Damage to the skin basement membrane due to the decomposition and reduced production of these structural components is considered a direct cause of skin aging, such as wrinkle formation and decreased elasticity. Laminin 332(5), a structural component of the basement membrane, plays a crucial role in providing security between the epidermis and dermis by firmly anchoring them; its expression is significantly reduced in skin of people in their 60s compared to those in their 30s. Furthermore, it has been reported that in damaged skin, the production of laminin 332(5) promotes regeneration at the site of injury, and in artificial skin models, external administration of laminin 332(5) promotes the formation of the skin basement membrane assembly (Journal of Dermatological Science. 25, pp. 51-59, 2000).
[0005] It has been reported that type XVII collagen, as another factor, is also a hemidesmosome component necessary for the stable attachment of the epidermis and dermis. When type XVII collagen is lacking, epidermal glaucoma, cutaneous atrophy, and a reduction in the epidermal stem cell population are observed (Journal of Investigative Dermatology. 129, 2288-2295, 2009).
[0006] In the dermis, oxidative phosphorylation, known for its high energy efficiency, is the most important process. However, due to external environmental stress, mitochondrial DNA damage accumulates. When the structure of the complex protein synthesized from this DNA is deformed, the mitochondrial membrane potential difference used for energy production cannot be formed, and oxidative phosphorylation cannot proceed normally. Consequently, the production of adenosine triphosphate (ATP) decreases, and electron leakage increases, leading to an increase in reactive oxygen species. Therefore, when the supply to skin cells is not smooth, cells undergo glycolysis through non-mitochondrial mechanisms to compensate for this energy deficiency. In particular, it has been reported that collagen glycation products, which account for 90% of the dermis, tend to accumulate, increasing intracellular oxidative stress and reducing dermal contractile energy, resulting in decreased skin elasticity, wrinkle formation, and changes in skin color (J. Soc. Cosmet. Scientists Korea, 38(3), 237-245, 2012).
[0007] On the other hand, levans, primarily found in microbial products and recently also discovered in the roots of various herbs and trees, as well as plants such as barley and wheat, are β(2→6)-linked fructose polymers with hundreds of thousands of fructose residues. They are produced by multiple microorganisms (Bacillus subtilis, Bacillus polymyxa, Aerobacter levanicum, Streptococcus sp., Pseudomonas sp., Corynebacterium laevaniformans, Zymomonas mobilis, etc.) using sucrose as a matrix. Levans exhibit excellent moisturizing effects in the skin and are completely non-toxic to cells, making them suitable for use as raw materials in cosmetic compositions.
[0008] Existing technical documents
[0009] Patent documents
[0010] Patent Document 1: EP 02714705 B1 Summary of the Invention
[0011] The inventors conducted research to discover cosmetic compositions that can prevent or improve wrinkle formation, decreased elasticity, atrophy, dryness, and skin damage caused by changes in skin structure and properties. As a result, it was found that, compared to compositions containing only one or two ingredients, cosmetic compositions containing (i) sucralfate, (ii) fructan, and (iii) hyaluronic acid, their salts, or derivatives thereof exhibit significant wound healing effects, restoration of dysregulated gene transcription or protein expression caused by ultraviolet B radiation, strengthening of the dermal-epidermal junction (DEJ), and skin regeneration effects, thus completing this invention.
[0012] Therefore, the object of the present invention is to provide a cosmetic composition for skin regeneration comprising i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0013] Another object of the present invention is to provide a cosmetic composition for improving skin elasticity comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0014] Another object of the present invention is to provide a cosmetic composition for improving wrinkles comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0015] Another object of the present invention is to provide a skin moisturizing cosmetic composition comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0016] Another object of the present invention is to provide a cosmetic composition for improving skin damage comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0017] According to one embodiment of the present invention, the present invention provides a cosmetic composition for skin regeneration comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0018] Furthermore, the present invention provides the use of the composition in skin regeneration, the composition comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, its salt or derivative thereof.
[0019] The inventors have conducted research to discover cosmetic compositions that can prevent or improve wrinkle formation, decreased elasticity, atrophy, dryness, and skin damage caused by changes in skin structure and properties. As a result, it has been determined that, compared to compositions containing only one or two of the ingredients, cosmetic compositions containing (i) sucralfate, (ii) fructan, and (iii) hyaluronic acid, their salts, or derivatives thereof exhibit significant wound healing effects, restoration of transcriptional or protein expression disordered by ultraviolet radiation, strengthening of the dermal-epidermal junction (DEJ), and skin regeneration effects.
[0020] The skin regeneration cosmetic composition of the present invention has the effect of increasing the expression of laminin 332(5), type XVII collagen and filaggrin, guiding the expression of peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) and cell growth, thereby having the function of activating cells. Furthermore, it reduces the expression of interleukin-6 (IL-6) protein, thereby having a skin-soothing function.
[0021] In this specification, the term "cosmetic composition" means a composition used for the purpose of cleansing, beautifying, maintaining or promoting the health of the skin.
[0022] In this specification, the term "sucralfate" refers to the compound represented by the following chemical formula 1, which is the basic aluminum salt of sucrose octasulphate.
[0023] Chemical Formula 1
[0024]
[0025] In this specification, the term "fructose" refers to a compound in which at least one fructose residue constitutes the majority of the bonds. Furthermore, the fructose of this invention includes polysaccharides in which fructose is linked by β-(2,1)-bonding and / or β-(2,6)-bonding, and oligosaccharides or polysaccharides in which at least two fructose residues are bound to a glucose molecule. In this specification, the chain length of the fructose is at least 3, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 40, or at least 50 chains. In this specification, the fructose may be inulin, levan, phlein, or graminin, but is not limited to these.
[0026] In one specific embodiment of the present invention, the fructans described above comprise linear chains and / or side chains.
[0027] In another specific embodiment of the present invention, the aforementioned fructan can be a modified fructan. For example, modified fructans include etherified fructans, esterified fructans, dihydroxyinulin, etc., but are not limited thereto.
[0028] In another specific embodiment of the present invention, the above-mentioned fructan is an oligofructose with 2 to 20 glucosylfructose units.
[0029] In another specific embodiment of the present invention, the above-mentioned fructan is a β-(2,6) fructose polymer containing β-(2,1) side chains.
[0030] In one embodiment of the present invention, the fructan has a content of 2000 Da to 100000 kDa.
[0031] In one embodiment of the present invention, the sucralfate contains 0.01% (w / v) to 1.0% (w / v) relative to the above composition.
[0032] In another embodiment of the invention, the sucralfate comprises 0.05% (w / v) to 0.5% (w / v), 0.05% (w / v) to 0.4% (w / v), 0.05% (w / v) to 0.3% (w / v), 0.05% (w / v) to 0.2% (w / v), 0.05% (w / v) to 0.1% (w / v), 0.1% (w / v) to 0.5% (w / v), 0.1% (w / v) to 0.4% (w / v), 0.1% (w / v) to 0.3% (w / v), or 0.1% (w / v) to 0.2% (w / v) relative to the above composition.
[0033] In one embodiment of the present invention, in the above composition, (i) the above-mentioned sucralfate, (ii) fructan and (iii) hyaluronic acid, their salts or derivatives thereof are in a weight ratio of 1:1:1 to 1:5:0.1.
[0034] In another embodiment of the invention, the weight ratios described above are 1:1:1 to 1:5:0.1, 1:1:1 to 1:5:0.2, 1:1:1 to 1:5:0.5, 1:1:1 to 1:5:1, 1:1:1 to 1:4:0.1, 1:1:1 to 1:4:0.2, 1:1:1 to 1:4:0.5, 1:1:1 to 1:4:1, 1:1:1 to 1:3:0.1, 1:1:1 to 1:3:0.2, 1:1:1 to 1:3:0.5, 1:1:1 to 1:3:1, 1:1:1 to 1:2:0.1, 1:1:1 to 1:2:0.2, 1:1:1 to 1:2:0.5, or 1:1:1 to 1:2:1. In another embodiment of the invention, the weight ratio is from 1:5:0.1 to 1:5:0.5. In yet another embodiment of the invention, the weight ratio is 1:5:0.2.
[0035] In one embodiment of the present invention, the fructan is levan, inulin, timothy fructan, rye fructose gum, or a combination thereof.
[0036] In one embodiment of the present invention, the fructan has a content of 2000 Da to 100000 kDa.
[0037] In this specification, the term "levan" refers to a β-2,6-linked fructan having β-2,1-linked side chains.
[0038] The aforementioned L-glycans can be produced from bacteria and / or plants. The aforementioned L-glycans can range from 2000 Da to 33000 Da. The aforementioned L-glycans can range from 2000 kDa to 100000 kDa.
[0039] The bacteria mentioned above are selected from one or more of the group consisting of Bacillus subtilis, Bacillus polymyxa, L. aerogenes, Streptococcus, Pseudomonas, Corynebacterium, and Motile fermentation mononucleosis, but are not limited thereto.
[0040] In one embodiment of the present invention, the salt or derivative of the aforementioned hyaluronic acid is sodium acetylated hyaluronate, sodium hyaluronate, potassium hyaluronate, hydrolyzed hyaluronic acid, hydrolyzed sodium hyaluronate, sodium hyaluronate crosspolymer, hydroxypropyltrimonium hyaluronate, oligo hyaluronic acid, or a combination thereof.
[0041] In this specification, the term "sodium acetylated hyaluronate" refers to a derivative of sodium hyaluronate in which the hydroxyl group is replaced by an acetyl group, and can be abbreviated as sodium acetylated HA.
[0042] It is known in the art that, compared with hyaluronic acid, the above-mentioned acetylated sodium hyaluronate exhibits a significant moisturizing effect in the skin.
[0043] In one embodiment of the present invention, the molecular weight of the hyaluronic acid, its salt or derivative thereof is from 5,000 Da to 1,500,000 Da.
[0044] In one embodiment of the present invention, the above composition further includes the expression or transcription of one or more proteins or genes encoding the thereof selected from the group consisting of laminin 332 (laminin 5), type XVII collagen, peroxisome proliferator-activated receptor gamma coactivator 1-alpha, and filaggrin.
[0045] In this specification, the term "laminin" refers to an extracellular glycoprotein that is an important structural component of all basement membranes, assembled as a heterotrimer αβγ formed by α, β and γ chains, and which exists in at least 16 isoforms in mammals.
[0046] In this specification, the term "lamin 332" refers to a heterotrimeric protein formed from the α3, β3, and γ2 chains previously known as laminin 5. It is an essential structural component of the dermal-epidermal junction (DEJ), a region of the basement membrane that provides resistance to skin integrity and external mechanical forces by attaching the epidermis to the dermis. Laminin 332 (laminin 5) plays a crucial role in the epithelial tissue of basement membrane adhesion through its interaction with either α6β4 or α3β1 integrin, which act as two receptors.
[0047] In this specification, the term "type XVII collagen" refers to type II transmembrane collagen, also known as BP180 (180kDa bullouspemphigoid antigen) or BPAG2, which is expressed in the epithelial hemidesmosomes of the skin, mucous membranes, and eyes.
[0048] In this specification, the term "filament-aggregating protein" refers to the structural protein necessary for the development and maintenance of the skin barrier, as it causes the aggregation and compression of keratin intermediates.
[0049] In this specification, the term "peroxisome proliferator-activated receptor gamma coactivator 1-alpha" refers to a transcriptional coactivator that can enhance mitochondrial biosynthesis, respiratory capacity, oxidative phosphorylation, and fatty acid β-oxidation.
[0050] In one embodiment of the present invention, the above composition reduces the expression or transcription of the protein of interleukin-6 or the gene encoding it.
[0051] In this specification, the term "interleukin-6" refers to a water-soluble mediator with pleiotropic effects on inflammatory immune responses and hematopoiesis, acting as a pro-inflammatory cytokine and an anti-inflammatory myokine.
[0052] According to another embodiment of the present invention, the present invention provides a cosmetic composition for improving skin elasticity comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0053] Furthermore, the present invention provides the use of the composition in improving skin elasticity, the composition comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, its salt or derivative thereof.
[0054] According to another embodiment of the present invention, the present invention provides a cosmetic composition for improving wrinkles comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0055] Furthermore, the present invention provides the use of the composition in improving wrinkles, the composition comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, its salt or derivative thereof.
[0056] According to another embodiment of the present invention, the present invention provides a skin moisturizing cosmetic composition comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0057] Furthermore, the present invention provides the use of the composition in skin moisturizing, the composition comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, its salt or derivative thereof.
[0058] According to another embodiment of the present invention, the present invention provides a cosmetic composition for improving skin damage comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0059] Furthermore, the present invention provides the use of the composition in improving skin damage, the composition comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, its salt or derivative thereof.
[0060] In one embodiment of the present invention, the aforementioned skin damage was caused by ultraviolet radiation.
[0061] In another embodiment of the invention, the aforementioned skin damage is caused by external stimuli. In yet another embodiment of the invention, the external stimuli may be exposure to pollution, micro-dust, or ultrafine dust. In yet another embodiment of the invention, the aforementioned skin damage is caused by stress or aging.
[0062] In this specification, the term "improvement" means all actions that maintain or promote skin health.
[0063] In one embodiment of the present invention, the cosmetic composition of the present invention may contain (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, their salts or derivatives thereof as active ingredients, and ingredients commonly used in cosmetic compositions, such as antioxidants, stabilizers, solubilizers, vitamins, pigments and fragrances, as well as carriers.
[0064] The aforementioned carriers can be monohydric alcohols (ethanol or propanol), polyhydric alcohols (glycerol, 1,3-butanediol or propylene glycol), higher fatty acids (palmitic acid or linolenic acid), oils (wheat germ oil, camellia oil, jojoba oil, olive oil, squalane, sunflower seed oil, macadamia nut oil, avocado oil, hydrogenated soybean lecithin or fatty acid glycerides), etc., but are not limited to these. Furthermore, surfactants, bactericides, antioxidants, UV absorbers, anti-inflammatory agents, and cooling agents can be added as needed.
[0065] The surfactants mentioned above can be polyoxyethylene, hydrogenated castor oil, polyoxyethylene, oil-based ether, polyoxyethylene monooleate, polyoxyethylene, glyceryl monostearate, sorbitol monostearate, polyoxyethylene monooleate, sorbitol, sucrose fatty acid ester, glyceryl monolaurate, polyoxyethylene reduced lanolin, polyethoxylated fatty alcohol (POE), glyceryl pyroglutamic acid, isostearic acid, diester, N-acetylglutamine, and isostearate, etc., but are not limited to these.
[0066] The aforementioned bactericides may include hydrothiophene, triclosan, chlorhexidine gluconate, phenoxyethanol, resorcinol, isopropyl methylphenol, azulene, salicylic acid, zinc pyridone, etc., but are not limited to these.
[0067] The antioxidants mentioned above can be used as long as they are composed of one or more of butylated hydroxyanisole, gallic acid, propyl gallate and isoascorbic acid.
[0068] The ultraviolet absorbers mentioned above can be benzophenones such as dihydroxybenzophenone, melanin, ethyl p-aminobenzoate, 2-ethylhexyl p-dimethylaminobenzoate, Sinosit, 2-ethylhexyl p-methoxycinnamate, 2-(2-hydroxy-5-methylphenyl)benzotriazole, uric acid, and metal oxide microparticles, but are not limited to these.
[0069] The anti-inflammatory agents mentioned above can be dipotassium glycyrrhizate, allantoin, etc., and the cooling agents can be red pepper tincture, 1-menthol, etc., but are not limited to these.
[0070] In one embodiment of the present invention, the above-mentioned cosmetic composition may be formulated into a dosage form selected from the group consisting of solutions, topical ointments, gels, creams, foams, lotions, toners, skin softeners, astringents, moisturizing lotions, nourishing lotions, massage creams, nourishing creams, moisturizing creams, hand creams, lotions, nourishing toners, softening lotions, face masks, smoothing lotions, emulsions, base makeup, serums, nourishing serums, ampoules, hair ampoules, scalp care products, hair growth products, conditioners, hair care products, hair conditioners, shampoos, rinse-out conditioners, conditioner shampoos, hair-nourishing shampoos, hair gels, hair waxes, hair gels, dyes, soaps, facial cleansers, facial foams, facial cleansers, cleansing creams, bath additives, shower gels, sunscreens, sun oils, suspensions, emulsions, pastes, powders, soaps, facial cleansers containing surfactants, oils, foundations, foundations, emulsion foundations, wax foundations, patches, and sprays, but is not limited thereto.
[0071] The cosmetic composition of the present invention may be further supplemented with ingredients selected from the group consisting of water-soluble vitamins, active vitamins, high molecular weight peptides, high molecular weight polysaccharides, sphingolipids, and seaweed extracts.
[0072] Water-soluble vitamins can be used in any substance as long as they are water-soluble vitamins that can be combined with cosmetic compositions. Preferably, the water-soluble vitamins that can be used in this invention include vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine hydrochloride, vitamin B12, pantothenic acid, niacin, niacinamide, folic acid, vitamin C, vitamin H, and their salts (thiamine hydrochloride, sodium ascorbate, etc.) or derivatives (sodium ascorbate 2-phosphate, magnesium ascorbate 2-phosphate, etc.). Water-soluble vitamins can be produced by general microbial transformation methods, microbial culture purification methods, enzymatic methods, or chemical synthesis methods.
[0073] Useful vitamins can be any substance as long as they are compatible with cosmetic compositions. Preferably, water-soluble vitamins that can be used in this invention include vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (d1-α-tocopherol, d-α-tocopherol, d-α-tocopherol) and their derivatives (ascorbyl palmitate, ascorbyl stearate, ascorbyl palmitate, dl-α-tocopherol acetate, dl-α-tocopherol nicotinate, vitamin E, DL-panthenol, D-panthenol, panthenyl ethyl ether, etc.). Useful vitamins can be produced by general microbial transformation, microbial culture purification, enzymatic methods, or chemical synthesis.
[0074] High molecular weight peptides can be used with any substance as long as they are compatible with cosmetic compositions. Preferably, they can be collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, keratin, etc. High molecular weight peptides can be produced by general microbial culture purification methods, enzymatic methods, or chemical synthesis methods, or are usually purified from natural substances such as pig or cow dermis, silk fibers, etc.
[0075] Any polymeric polysaccharide that can be incorporated into a cosmetic composition can be used. Preferably, it can be hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or its salts (sodium salt, etc.). For example, chondroitin sulfate or its salts can usually be purified from mammals or fish before use.
[0076] Sphingolipids can be any substance as long as they are compatible with cosmetic compositions. Preferably, they can be ceramides, phytosphingosine, glycosphingolipids, etc. Sphingolipids are usually purified from mammals, fish, shellfish, yeast, or plants by conventional methods or formed through chemical synthesis.
[0077] Any seaweed extract that can be incorporated into a cosmetic composition can be used. Preferably, it can be brown algae extract, red algae extract, green algae extract, etc. Furthermore, the seaweed extract used in this invention includes carrageenan, arginine, sodium alginate, potassium alginate, etc., purified from these seaweed extracts. The seaweed extract is purified from seaweed using conventional methods.
[0078] The cosmetic compositions of the present invention may also be combined with other ingredients that are typically combined with cosmetic compositions.
[0079] In addition, the ingredients that can be added include oils, moisturizers, emollients, surfactants, organic and inorganic pigments, organic powders, UV absorbers, preservatives, bactericides, antioxidants, plant extracts, pH adjusters, alcohols, pigments, fragrances, blood circulation enhancers, cooling agents, antiperspirants, purified water, etc.
[0080] As components of oils, they can be ester oils, hydrocarbon oils, silicone oils, fluorinated oils, animal oils, vegetable oils, etc.
[0081] Ester oils can be tris(2-ethylhexanoate) glyceryl, 2-ethylhexanoate cetyl, isopropyl myristate, butyl myristate, isopropyl palmitate, ethyl stearate, octyl palmitate, isocetyl isostearate, butyl stearate, ethyl linoleate, isopropyl linoleate, ethyl oleate, isocetyl myristate, isostearyl myristate, isostearyl palmitate, octyl dodecyl myristate, isocetyl isostearate, diethyl sebacate, diisopropyl adipate, isoalkyl neopentanoate, tri(octyl, decanoic acid) glyceryl, trimethylolpropane tris(2-ethylhexanoate), trimethylolpropane triisostearate, tetramethylolpropane triisostearate, tetraethyl myristate ... 2-Ethylhexanoate pentaol, cetyl octanoate, decyl laurate, hexyl laurate, decyl myristate, myristyl stearate, cetyl myristate, stearyl stearate, decyl oleate, cetyl castor oil, isostearyl laurate, isotriadecyl myristate, octyl palmitate, octyl stearate, isocetyl stearate, isodecanyl oleate, octyl dodecyl oleate, octyl dodecyl linoleate, isopropyl isostearate, 2-ethylhexanoate cetearyl, 2-ethylhexanoate stearyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol didecanoate, di(octyl) Propylene glycol (decanoic acid), propylene glycol dicaprylate, neopentyl glycol dicaprylate, neopentyl dicaprylate, ethylene glycol, tricaprylate, tricaprylate, tricarboxylate, triisopalmitate, triisostearate, octyl dodecyl ester, isostearate, octyl isononanoate, decyl neodecanoate, octyl neodecanoate, isocetyl isostearate, isostearate, octyl decyl isostearate, polyglycerol oleate, polyglycerol isostearate, triisoceryl citrate, triisoalkyl citrate, triisooctyl citrate, lauryl lactate, myristyl lactate, cetyl lactate, lactic acid Octyl decyl ester, triethyl citrate, acetyl triethyl citrate, acetyl tributyl citrate, trioctyl citrate, dimalate isostearate, 2-ethylhexyl hydroxystearate, di-2-ethylhexyl succinate, diisobutyl adipate, diisopropyl sebacate, dioctyl sebacate, cholesterol stearate, cholesterol isostearate, cholesterol hydroxystearate, cholesterol oleate, dihydrocholesterol oleate, phytol isostearate, phytol oleate, 12-stearoyl hydroxystearate isocetyl ester, 12-stearoyl hydroxystearate, 12-stearoyl hydroxystearate isostearate, etc.
[0082] Hydrocarbon oils can be squalene, liquid paraffin, α-olefin oligomers, isoparaffins, pure terrestrial wax, paraffin, liquid isoparaffins, polybutene, microcrystalline wax, petrolatum, etc.
[0083] Silicone oils can be polymethylsiloxane, methylphenylsiloxane, methylcyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecylcyclosiloxane, dimethylsiloxane / methylhexadecyloxysiloxane copolymer, dimethylsiloxane / methylstearoxysiloxane copolymer, alkyl-modified silicone oil, amino-modified silicone oil, etc.
[0084] Fluorinated oils can be perfluoropolyethers, etc.
[0085] Animal or vegetable oils can include avocado oil, almond oil, olive oil, sesame oil, rice bran oil, bird's eye oil, soybean oil, corn oil, rapeseed oil, almond oil, palm kernel oil, palm oil, castor oil, sunflower seed oil, grapeseed oil, cottonseed oil, coconut oil, Kukui argan oil, wheat germ oil, rice germ oil, shea butter, evening primrose oil, makdamia nut oil, meadowsweet oil, egg yolk oil, butter, horse oil, mink oil, citronella oil, jojoba oil, candelilla oil hair wax, canna lily wax, liquid lanolin, hardened castor oil, etc.
[0086] Moisturizers can be water-soluble low-molecular-weight moisturizers, lipid-soluble molecular-weight moisturizers, water-soluble high-molecular-weight moisturizers, lipid-soluble high-molecular-weight moisturizers, etc.
[0087] Water-soluble low-molecular-weight moisturizers can include serine, glutamine, sorbitol, mannitol, sodium pyrrolidone formate, glycerin, propylene glycol, 1,3-butanediol, ethylene glycol, polyethylene glycol B (degree of polymerization n=2 or higher), polypropylene glycol (degree of polymerization n=2 or higher), polyglycerol B (degree of polymerization n=2 or higher), lactic acid, lactate, etc.
[0088] Lipid-soluble humectants can be cholesterol, cholesterol esters, etc.
[0089] Water-soluble polymers can include carboxyvinyl polymers, polyaspartic acid esters, astragalus gum, xanthan gum, methylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, carboxymethylcellulose, water-soluble chitin, chitosan, dextrin, etc.
[0090] Fat-soluble polymers can include polyvinylpyrrolidone / eicosene copolymer, polyvinylpyrrolidone / hexadecene copolymer, nitrocellulose, dextrin fatty acid ester, polymeric organosilicon, etc.
[0091] Emollients can be long-chain acylglutamic acid cholesterol ester, hydroxystearic acid cholesterol ester, 12-hydroxystearic acid, stearic acid, rosin acid, lanolin fatty acid cholesterol ester, etc.
[0092] Surfactants can be nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, etc.
[0093] Nonionic surfactants can be self-emulsifying glyceryl monostearate, propylene glycol fatty acid esters, glyceryl fatty acid esters, polyglycerol fatty acid esters, sorbitol fatty acid esters, POE (polyoxyethylene) sorbitol fatty acid esters, POE sorbitol fatty acid esters, POE glyceryl fatty acid esters, POE alkyl esters, POE fatty acid esters, POE hydrogenated castor oil, POE castor oil, POE / POP (polyoxyethylene / polyoxypropylene) copolymers, POE / POP alkyl ethers, polyether-modified silicones, lauric acid alkanolamides, alkyl amine oxides, hydrogenated soybean lecithin, etc.
[0094] Anionic surfactants can be fatty acid soaps, α-acylsulfonates, alkylsulfonates, alkylallyl sulfonates, alkylnaphthalene sulfonates, alkyl sulfates, POE alkyl ether sulfates, alkylamide sulfates, alkyl phosphates, POE alkyl phosphate trisalates, alkylamide phosphates, alkylacylalkyl taurines, N-acyl amino acid salts, POE alkyl ether carboxylates, alkyl sulfosuccinates, sodium alkyl sulfoacetate, acylated hydrolyzed collagen peptide salts, perfluoroalkyl phosphates, etc.
[0095] Cationic surfactants can be alkyltrimethylammonium chloride, stearyltrimethylammonium chloride, stearyltrimethylammonium bromide, cetearyltrimethylammonium chloride, distearate dimethylammonium chloride, stearyldimethylbenzylammonium chloride, docosyltrimethylammonium bromide, benzalkonium chloride, distearate ethylaminoacetamide, stearate dimethylaminopropionamide, lanolin derivative quaternary ammonium salts, etc.
[0096] Amphoteric surfactants can be of various types, including carboxybetaine, amide betaine, sulfobetaine, hydroxysulfobetaine, amide sulfobetaine, phosphate betaine, aminocarboxylate, imidazoline derivative, and amide amine.
[0097] Organic and inorganic pigments can include inorganic pigments such as silicic acid, anhydrous silicic acid, magnesium silicate, talc, sericite, mica, kaolin, Bengal clay, clay, bentonite, titanium-plated mica, bismuth oxychloride, zirconium oxide, magnesium oxide, zinc oxide, titanium oxide, aluminum oxide, calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, ultramarine, chromium oxide, chromium hydroxide, calamine and its complexes; and organic pigments such as polyamide, polyester, polypropylene, polystyrene, polyurethane, vinyl resin, urea resin, phenolic resin, fluororesin, silicone resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, divinylbenzene / styrene copolymer, silk powder, cellulose, CI pigment yellow, CI pigment orange, etc., as well as inorganic pigments of these and composite pigments of organic pigments.
[0098] Organic powders can be metal soaps such as calcium stearate; alkyl phosphate metal salts such as sodium zinc cetylate, zinc laurate, and calcium laurate; polyvalent metal salts of acyl amino acids such as calcium N-lauroyl-β-alanine, zinc N-lauroyl-β-alanine, and calcium N-lauroylglycinate; polyvalent metal salts of amide sulfonic acids such as calcium N-lauroyl taurate and calcium N-palmitoyl taurate; N-acyl basic amino acids such as N-ε-lauroyl-L-lysine, N-ε-palmitoylazine, N-α-glutamylornithine, N-α-lauroyl arginine, and N-α-hardened beef fatty acid acyl arginine; N-lauroyl glycyl glycine; α-amino fatty acids such as α-aminooctanoic acid and α-aminolauric acid; polyethylene, polypropylene, nylon, polymethyl methacrylate, polystyrene, divinylbenzene-styrene copolymer, and tetrafluoroethylene.
[0099] UV absorbers can be p-aminobenzoic acid, ethyl p-aminobenzoate, amyl p-aminobenzoate, octyl p-aminobenzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, butyl styrene salicylate, menthol salicylate, benzyl cinnamate, 2-ethoxyethyl cinnamate, octyl p-methoxycinnamate, di-2-ethylhexaneglycerol di-methoxycinnamate, isopropyl p-methoxycinnamate, and a mixture of diisopropyl-diisopropylcinnamate. Compounds, urocanic acid, ethyl urocanate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenone sulfonic acid and its salts, dihydroxymethoxybenzophenone, sodium dihydroxymethoxybenzophenone disulfonate, dihydroxybenzophenone, tetrahydroxybenzophenone, 4-tert-butyl-4'-methoxybenzoylmethane, 2,4,6-triphenylamino-p-(carbon-2'-ethylhexyl-1'-oxy)-1,3,5-triazine, 2-(2-hydroxy-5-methylphenyl)benzotriazole, etc.
[0100] Fungicides can include physalisol, triclosan, trichlorohydroxydiphenyl ether, chlorhexidine gluconate, phenoxyethanol, resorcinol, isopropyl methylphenol, chamomile, salicylic acid, zinc thione, benzalkonium chloride, photosensitizer 301, sodium mononitrate, undecanoic acid, etc.
[0101] Antioxidants can include butylated hydroxyanisole, propyl gallate, sorbic acid, etc.
[0102] pH adjusters can include citric acid, sodium citrate, malic acid, sodium malate, fumaric acid, sodium fumarate, succinic acid, sodium succinate, sodium hydroxide, disodium hydrogen phosphate, etc.
[0103] The alcohols can be higher alcohols such as cetyl alcohol.
[0104] Furthermore, the ingredients that can be added are not limited to these, and any of the above ingredients can be added within the scope of not impairing the purpose and effect of the present invention. Preferably, they can be added at 0.01% to 5% by weight relative to the total weight, and more preferably, at 0.01% to 3% by weight.
[0105] The cosmetic composition of the present invention can be in the form of solution, emulsion, viscous mixture, etc.
[0106] The ingredients included in the cosmetic compositions of the present invention, as active ingredients, may include, in addition to the extracts described above, ingredients commonly used in cosmetics, such as stabilizers, solubilizers, vitamins, pigments, and fragrances, as well as common auxiliary agents and carriers.
[0107] When the cosmetic composition of the present invention is in the form of a paste, cream or gel, the carrier component may be animal fiber, plant fiber, wax, paraffin, starch, brittle gum, cellulose derivatives, polyethylene glycol, organosilicon, bentonite, silica, talc or zinc oxide, etc.
[0108] When the cosmetic composition of the present invention is in the form of a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder can be used as the carrier component. In particular, in the case of a spray, propellants including chlorofluorocarbons, propane / butane or dimethyl ether can be added.
[0109] When the cosmetic composition of the present invention is in the form of a solution or emulsion, a solvent, solvator or emulsifier may be used as the carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butanediol oil, glycerol aliphatic ester, polyethylene glycol or dehydrated sorbitol fatty acid ester.
[0110] When the cosmetic composition of the present invention is in the form of a suspension, the carrier component may be a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitol ester, microcrystalline cellulose, aluminum hydroxide, bentonite, agar or thorn gum, etc.
[0111] In the case where the cosmetic formulation of the present invention is a detergent containing a surfactant, the carrier component may include fatty alcohol sulfates, fatty alcohol ether sulfates, sulfosuccinate monoesters, hydroxyethyl sulfonates, imidazoline derivatives, methyl taurate, sarcosinates, fatty acid amide ether sulfates, alkyl amide betaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolenic acid derivatives, or ethoxylated glycerol fatty acid esters.
[0112] In one example of the present invention, compared with compositions containing only sucralfate as an active ingredient and compositions containing two ingredients (sucralfate and fructan and sucralfate and acetylated sodium hyaluronate), the skin regeneration cosmetic composition of the present invention is characterized by increasing the expression of laminin 332 (laminin 5), a structural component of the basement membrane that firmly fixes the epidermis and dermis to impart stability to the skin. This promotes the regeneration of skin damaged areas caused by exposure to ultraviolet radiation, etc. It also increases the expression of type XVII collagen, a structural component of hemidesmosomes necessary for stable attachment between the epidermis and dermis; increases the gene transcription level of peroxisome proliferator-activated receptor γ coactivator-1α, a transcriptional co-active factor regulating mitochondrial oxidative phosphorylation; increases the expression of filaggrin, a structural protein necessary for the development and maintenance of the skin barrier; and reduces the protein expression of interleukin-6, which is increased due to ultraviolet radiation. These results in excellent skin elasticity improvement, wrinkle improvement, skin moisturizing, skin barrier strengthening, and skin damage improvement. The synergistic effect of the cosmetic composition of the present invention has been verified.
[0113] The features and advantages of this invention are briefly described below:
[0114] (a) The present invention provides a cosmetic composition for skin regeneration comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0115] (b) The present invention provides a cosmetic composition for improving skin elasticity comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0116] (c) The present invention provides a cosmetic composition for improving wrinkles comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0117] (d) The present invention provides a skin moisturizing cosmetic composition comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0118] (e) The present invention provides a cosmetic composition for improving skin damage comprising (i) sucralfate, (ii) fructan and (iii) hyaluronic acid, salts thereof or derivatives thereof.
[0119] (f) When using the skin regeneration cosmetic composition of the present invention, the expression of laminin 332 (laminin 5) and type XVII collagen, which are reduced due to ultraviolet radiation, is increased, thereby having the effect of firmly binding the skin structure; the expression of peroxisome proliferator-activated receptor γ coactivator-1α gene is increased and excellent wound healing effect is exhibited, thus it can be effectively used for skin damage recovery; the expression of filaggrin is increased, thereby having the effect of strengthening the skin barrier; and the expression of interleukin-6 protein is reduced, thereby effectively used for skin soothing. Attached Figure Description
[0120] Figure 1 The results show the effectiveness of wound healing after treating the compositions of Comparative Examples 1 to 3 and Example 1 with fibroblast scraping.
[0121] Figure 2a The results show the protein expression levels of laminin 5 and type XVII collagen after treating the compositions of Comparative Examples 1 to 3 and Example 1 respectively with ultraviolet light after irradiating keratinocytes (A431 cells).
[0122] Figure 2b Showing based on Figure 2a The results of Western blotting are used to represent the protein expression ratios of laminin 5 and type XVII collagen for β-actin.
[0123] Figure 3 The results show the messenger RNA levels of the peroxisome proliferator-activated receptor γ coactivator-1α gene after treating the compositions of Comparative Examples 1 to 3 and Example 1 respectively with ultraviolet light irradiation of fibroblasts.
[0124] Figure 4 The results show the results of confirming the expression level of interleukin-6 protein after treating the compositions of Comparative Examples 1 to 3 and Example 1 respectively with ultraviolet light after irradiating keratinocytes (HaCaT cells). Detailed Implementation
[0125] The present invention will now be described in more detail through embodiments. These embodiments are merely for illustrating the invention more specifically, and the scope of the invention is not limited to these embodiments, as will be apparent to those skilled in the art to which this invention pertains.
[0126] Throughout this specification, unless otherwise stated, the percentage (%) used to indicate the concentration of a particular substance is as follows: solid / solid (weight / weight)%, solid / liquid (weight / volume)%, liquid / liquid (volume / volume)%.
[0127] Example
[0128] Preparation example: Preparation of the composition
[0129] The composition of the control group, Comparative Examples 1 to 3, and Example 1 used in this invention is prepared as shown in Table 1 below. In Table 1, HA is an abbreviation for hyaluronic acid. Hereinafter, each structural component described in Table 1 will be used with purified water as a carrier and will be appropriately diluted according to the experimental examples described later.
[0130] Table 1
[0131]
[0132]
[0133] Experiment Example 1: Evaluation of Wound Healing Effectiveness
[0134] In this experimental example, the cell regeneration capacity of Comparative Examples 1 to 3 and Example 1 was measured.
[0135] After seeding and culturing human fibroblasts in 24-well plates, SPLScar was used... TM A scraper was used to scratch the cells cultured in a monolayer to create wounds and the culture medium was changed. Subsequently, the cells were treated and cultured in the culture medium to achieve a final concentration of 0.05% (v / v) for Comparative Examples 1 to 3 and Example 1, respectively. The results, photographed under a microscope (Leica) one day later, are presented below. Figure 1 middle.
[0136] like Figure 1 As shown, the results confirm that the cell regeneration capacity of the treatment group of Example 1 of the present invention is superior compared with that of Comparative Examples 1 to 3.
[0137] Experimental Example 2: Evaluation of Reinforcement of the Dermal-Epidermal Junction
[0138] In this experimental example, the dermal-epidermal junction strengthening effect of Comparative Examples 1 to 3 and Example 1 was measured.
[0139] After inoculating A431 cells (a keratinocyte cell line) and culturing for one day, the cells were irradiated with 50 mJ / cm² ultraviolet light. 2 Subsequently, the medium was replaced with serum-free medium to treat and culture the samples in Comparative Examples 1 to 3 and Example 1 to achieve a final concentration of 0.1% (v / v). Pro-prep was used. TM Cells were collected by iNtRON and proteins were isolated according to the manufacturer's method. After quantification of the isolated proteins, polyacrylamide gel electrophoresis (SDS-PAGE) was performed, followed by transfer using the iBlot2 Dry Blotting system. Subsequently, a one-day reaction was carried out after treatment with primary antibodies against laminin 332(5) (Santa Cruz), type XVII collagen (Thermo Fisher Scientific), and β-actin (Santa Cruz). Next, secondary antibodies against mouse horseradish peroxidase (HRP) and rabbit horseradish peroxidase (rabbit HRP (Bio-Rad)) were treated and reacted, followed by protein detection using an Atto II chemiluminescence imaging system (Chemi Doc) (ATTO, Japan). The results are presented in Table 2 below. Figure 2a and Figure 2b middle.
[0140] Table 2
[0141]
[0142] As shown in Table 2, Figure 2a and Figure 2b As shown, it was confirmed that in the untreated control group, when the protein expression rates of laminin 5 and type XVII collagen relative to β-actin were set at 100%, the protein expression rates of laminin 5 and type XVII collagen in the UV irradiation group were reduced to 27.5% and 40.8%, respectively. The protein expression rates of laminin 5 and type XVII collagen, which were reduced due to UV irradiation, were increased in Comparative Examples 1 to 3.
[0143] In particular, the protein expression of laminin 5 and type XVII collagen, which was reduced due to ultraviolet irradiation, was significantly increased by the treatment in Example 1, to a degree that could not have been expected from Comparative Examples 1 to 3. The composition of Example 1, which contained sucralfate, fructan and acetylated sodium hyaluronate, exerted a synergistic effect.
[0144] Experimental Example 3: Evaluation of Skin Revitalizing
[0145] In this experimental example, the skin cell viability or mitochondrial biosynthetic efficacy of Comparative Examples 1 to 3 and Example 1 were measured.
[0146] After inoculating fibroblasts and culturing for one day, the cells were irradiated with ultraviolet light to treat and culture them in the medium to achieve a final concentration of 0.05% (v / v) as in Comparative Examples 1 to 3 and Example 1. The culture was then infused with QIAzol. TM Lysis Reagent (Qiagen) collected cells and isolated ribonucleic acid (RNA) according to the manufacturer's method. After quantification of the isolated RNA, complementary deoxyribonucleic acid (cDNA) was synthesized for real-time polymerase chain reaction (Real-Time PCR). Primers for peroxisome proliferator-activated receptor γ-coactivator-1α and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were synthesized and used by CosmoGenetech, and their sequences are shown in Table 3 below. The results of the real-time polymerase chain reaction are shown in Table 4 below. Figure 3 middle.
[0147] Table 3
[0148]
[0149] Table 4
[0150] distinguish PGC-1α gene expression rate (%) Control group (untreated group) 100.0 Ultraviolet irradiation group 37.7 Ultraviolet light + Example 1 79.1 Ultraviolet light + Comparative Example 1 49.6 Ultraviolet light + Comparative Example 2 60.2 Ultraviolet light + Comparative Example 3 48.2
[0151] As shown in Table 4 and Figure 3As shown, the results confirming the levels of peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) messenger RNA related to cell viability showed that in the untreated control group, when the PGC-1α mRNA level relative to glyceraldehyde-3-phosphate dehydrogenase was taken as 100%, the PGC-1α mRNA level was significantly reduced to 37.7% in the UV irradiation group compared to the control group. In Comparative Examples 1 to 3, the PGC-1α mRNA levels, which had been significantly reduced due to UV irradiation, increased to 48.2% to 60.2%.
[0152] In particular, in Example 1, the messenger RNA level of peroxisome proliferator-activated receptor γ coactivator-1α was significantly increased to 79.1%, which was unexpected from the results of Comparative Examples 1 to 3, thereby guiding mitochondrial biogenesis.
[0153] Experiment Example 4: Moisturizing Evaluation
[0154] In this experimental example, the skin moisturizing effects of Comparative Examples 1 to 3 and Example 1 were measured.
[0155] Human epidermal keratinocytes (HEKn cells) were seeded and cultured for one day, then treated and cultured to achieve a final concentration of 0.1% (v / v) as in Comparative Examples 1 to 3 and Example 1. QIAzol was used. TM Cells were collected using Lysis Reagent (Qiagen), and ribonucleic acid (RNA) was isolated according to the manufacturer's method. After quantification of the isolated RNA, complementary deoxyribonucleic acid (DNA) was synthesized, and real-time polymerase chain reaction (RT-PCR) was performed to confirm the messenger RNA levels of filaggrin. Primers for filaggrin and β-actin were synthesized and used by CosmoGenetech, and their sequences are shown in Table 5 below. The results of the R-PCR are shown in Table 6 below.
[0156] Table 5
[0157]
[0158] Table 6
[0159] distinguish filaggrin gene expression rate (%) Control group (untreated group) 100.0 Example 1 172.4 Comparative Example 1 121.0 Comparative Example 2 115.0 Comparative Example 3 138.1
[0160] As shown in Table 6, the results confirmed the messenger ribonucleic acid (RNA) levels of filaggrin, a known representative protein that plays a role in skin moisturizing. Compared with the control group, the RNA levels of filaggrin increased in Comparative Examples 1 to 3. In Example 1, the value was significantly increased compared with Comparative Examples 1 to 3.
[0161] If the results of treating Comparative Examples 1 to 3 are not expected, in the case of treating Example 1, the messenger ribonucleic acid level of filaggrin is significantly increased. Compared with the cases of treating each component alone or treating two components alone, the present inventors have achieved a synergistic effect in treating the composition of Example 1 containing sucralfate, fructan and acetylated sodium hyaluronate alone.
[0162] Experimental Example 5: Skin Soothing Evaluation
[0163] In this experimental example, the skin-soothing effects of Comparative Examples 1 to 3 and Example 1 were measured.
[0164] Human immortalized keratinocytes (HaCaT cells) were inoculated and cultured for one day, then irradiated with ultraviolet light at 30 mJ / cm². 2 The serum-free medium was replaced to treat the cells and culture them for 2 days to achieve a final concentration of 0.1% (v / v) as in Comparative Examples 1 to 3 and Example 1. Pro-prep was used. TM Cells were collected by iNtRON and proteins were isolated according to the manufacturer's method. After quantification of the isolated proteins, polyacrylamide gel electrophoresis was performed, followed by transfer using the iBlot2 dry transfer system. Subsequently, a one-day reaction was carried out after treatment with primary antibodies against interleukin-6 (Santa Cruz) and glyceraldehyde-6-phosphate dehydrogenase (Santa Cruz). Next, after treatment with secondary antibodies against mouse horseradish peroxidase and rabbit horseradish peroxidase (Bio-Rad) and subsequent reaction, protein detection was performed using an Atto II chemiluminescence imaging system (ATTO, Japan). The results are presented in Table 7 below. Figure 4 middle.
[0165] Table 7
[0166]
[0167]
[0168] As shown in Table 7, the results confirmed in each sample showed that in the UV irradiation group, when the proportion of interleukin-6 protein expression relative to glyceraldehyde-6 dehydrogenase was taken as 100%, the proportion of interleukin-6 protein expression was significantly increased compared to the control group. In the cases treated with Comparative Examples 1 to 3, the increase in interleukin-6 protein expression due to UV irradiation was reduced to 75.0% to 92.4%, and in the case treated with Example 1, the increase in interleukin-6 expression due to UV irradiation was significantly reduced to 55.1%.
[0169] The significant reduction in interleukin-6 protein expression due to ultraviolet irradiation by the composition of Example 1, which contains sucralfate, fructan, and acetylated sodium hyaluronate, is a synergistic effect that could not be expected from the reduction in interleukin-6 expression due to ultraviolet irradiation shown in Comparative Example 1, which contains sucralfate alone, Comparative Example 2, which contains sucralfate and fructan, and Comparative Example 3, which contains sucralfate and acetylated sodium hyaluronate.
[0170] Formulation example
[0171] On the other hand, the following describes formulation examples of cosmetic compositions for skin regeneration containing sucralfate of the present invention. However, these formulation examples are merely illustrative of the use of the present invention and are not intended to limit the scope of protection of the present invention to these formulation examples, as will be apparent to those skilled in the art.
[0172] Example 1 of cosmetic formulations: Skin lotion
[0173] Using the substance from Example 1 dissolved at a concentration of 2.0% (w / w) as a raw material, a skin care water was prepared according to the composition shown in Table 8 below. Glycerin, butylene glycol, propylene glycol, and preservative were added sequentially to purified water and stirred until dissolved to prepare a mixture. Polyoxyethylene-cured castor oil was heated to approximately 60°C and dissolved, then fragrance was added and dissolved before being added to the above mixture. Finally, a 2.0% aqueous solution of Example 1, ethanol, triethanolamine, and pigment were added and stirred thoroughly.
[0174] Table 8
[0175]
[0176] Example 2 of cosmetic formulation: Nourishing emulsion
[0177] Using the substance from Example 1 dissolved at a concentration of 2.0% (w / w) as a raw material, a nutritional emulsion was prepared according to the composition shown in Table 9 below. Propylene glycol, hydroxyl polymer, preservative, and purified water were mixed and stirred, heated to between 80°C and 85°C, and then added to the preparation unit. An emulsifier was then operated to dissolve beeswax, polysorbate 60, sorbitan sesquioleate, liquid paraffin, sorbitan stearate, glyceryl monostearate (lipophilic), stearic acid, glyceryl stearate / PEG-400 stearate, and triethanolamine, which were then heated to between 80°C and 85°C and emulsified. Upon completion of emulsification, the mixture was stirred with a mixer and cooled to 50°C. Fragrance was added and cooled to 45°C, followed by colorant. A 2.0% (w / w) aqueous solution of Example 1 was added at 35°C and cooled to 25°C.
[0178] Table 9
[0179]
[0180]
[0181] Example 3 of cosmetic formulations: face cream
[0182] Using the substance from Example 1 dissolved at a concentration of 2.0% (w / w) as a raw material, a nourishing face cream (total 100g) was prepared according to the composition shown in Table 10 below. After mixing and stirring hydroxyethylene polymer, butanediol, glycerin, and purified water, and heating to between 80°C and 85°C, the mixture was added to the preparation unit. An emulsifier was then used to dissolve stearic acid, cetyl alcohol, glyceryl monostearate, polyoxyethylene sorbitan monostearate, sorbitan sesquioleate, glyceryl monostearate / glyceryl stearate / polyoxyethylene stearate, hair wax, liquid paraffin, and caprylic / capric glyceryl ester, all heated to between 80°C and 85°C. Triethanolamine was then added and stirred before being added to the preparation unit for emulsification. Upon completion of emulsification, the mixture was stirred using a mixer and cooled to 35°C. A 2.0% (w / w) aqueous solution of Example 1 was then added and cooled to 25°C.
[0183] Table 10
[0184]
[0185]
Claims
1. Use of compositions comprising the following components (i) to (iii) in the manufacture of compositions for skin regeneration: (i) Sucralfate, (ii) Fructans, and (iii) Selected from one or more of the following ingredients: hyaluronic acid, sodium hyaluronate, potassium hyaluronate, sodium hyaluronate crosspolymer, and hydroxypropyltrimethylammonium chloride hyaluronic acid. The fructans mentioned therein are levofloxacin, timofloxacin, or a combination thereof.
2. The use according to claim 1, The hyaluronic acid mentioned above is hydrolyzed hyaluronic acid or oligomeric hyaluronic acid, and The sodium hyaluronate mentioned therein is acetylated sodium hyaluronate or hydrolyzed sodium hyaluronate.
3. The use according to claim 1, characterized in that, The composition contains 0.01 w / v% to 1.0 w / v% sucralfate relative to the above composition.
4. The use according to claim 1, characterized in that, In the above composition, the weight ratio of the above sucralfate, the above fructan and the above component (iii) is from 1:1:1 to 1:5:0.
1.
5. The use according to claim 1, characterized in that, The fructans mentioned above have a content of 2,000 Da to 100,000 kDa.
6. The use according to claim 1, characterized in that, The molecular weight of the above component (iii) is from 5,000 Da to 1,500,000 Da.
7. The use according to claim 1, characterized in that, The above composition increases the expression or transcription of one or more proteins or genes encoding the proteins selected from the group consisting of laminin 332, type XVII collagen, peroxisome proliferator-activated receptor gamma coactivator-1α, and filaggrin.
8. The use according to claim 1, characterized in that, The above composition reduces the expression or transcription of interleukin-6 protein or the gene encoding it.
9. Use of compositions comprising the following components (i) to (iii) in the manufacture of compositions for improving skin elasticity: (i) Sucralfate, (ii) Fructans, and (iii) Selected from one or more of the following ingredients: hyaluronic acid, sodium hyaluronate, potassium hyaluronate, sodium hyaluronate crosspolymer, and hydroxypropyltrimethylammonium chloride hyaluronic acid. The fructans mentioned therein are levofloxacin, timofloxacin, or a combination thereof.
10. Use of compositions comprising the following ingredients (i) to (iii) in the manufacture of compositions for improving wrinkles: (i) Sucralfate, (ii) Fructans, and (iii) Selected from one or more of the following ingredients: hyaluronic acid, sodium hyaluronate, potassium hyaluronate, sodium hyaluronate crosspolymer, and hydroxypropyltrimethylammonium chloride hyaluronic acid. The fructans mentioned therein are levofloxacin, timofloxacin, or a combination thereof.
11. Use of compositions comprising the following ingredients (i) to (iii) in the manufacture of compositions for skin moisturizing: (i) Sucralfate, (ii) Fructans, and (iii) Selected from one or more of the following ingredients: hyaluronic acid, sodium hyaluronate, potassium hyaluronate, sodium hyaluronate crosspolymer, and hydroxypropyltrimethylammonium chloride hyaluronic acid. The fructans mentioned therein are levofloxacin, timofloxacin, or a combination thereof.
12. Use of compositions comprising the following components (i) to (iii) in the manufacture of compositions for improving skin lesions: (i) Sucralfate, (ii) Fructans, and (iii) Selected from one or more of the following ingredients: hyaluronic acid, sodium hyaluronate, potassium hyaluronate, sodium hyaluronate crosspolymer, and hydroxypropyltrimethylammonium chloride hyaluronic acid. The fructans mentioned therein are levofloxacin, timofloxacin, or a combination thereof.
13. The use according to any one of claims 9 to 12, The hyaluronic acid mentioned above is hydrolyzed hyaluronic acid or oligomeric hyaluronic acid, and The sodium hyaluronate mentioned therein is acetylated sodium hyaluronate or hydrolyzed sodium hyaluronate.
Citation Information
Patent Citations
Sucrose octasulfates of magnesium, preparation method thereof and pharmaceutical and cosmetic uses of same
EP2714705B1
Cosmetic
JP2018188403A
Sucralfate used cosmetic composition and its manufacturing method
KR102364242B1
KR1020158570000B1
